April 5, 2010 — Annapolis-based PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, appointed Thomas R. Fuerst, Ph.D., as the company's Senior Vice President, Chief Scientific Officer. In this newly created role, Dr. Fuerst will oversee PharmAthene's research and development programs and provide strategic scientific direction for the company.
Dr. Fuerst is a senior biotechnology leader and former government official with over 20 years of experience in the research, development, and manufacturing of biological products, and strategic planning. He has served as a leader at the nexus of government, industry, and academia and brings to PharmAthene extensive scientific expertise and knowledge of state-of-the-art technologies and practices used in the discovery and development of vaccines and biotherapeutic products.
"Tom has dedicated his life and career to this industry and we are honored to have him as a new member of the PharmAthene team," said David P. Wright, Chief Executive Officer in statement. "His executive management experience in both government and private industry, coupled with specialized scientific and manufacturing expertise, will be a valuable asset to PharmAthene as we pursue our goal of becoming the leading provider of medical countermeasures to the U.S. government."
Source: PharmAthene, Inc.
| Visionary: The Odyssey of Sir Arthur C. Clarke April 2, 2012 - Visionary offers the first full-life chronicle of the man whose fiction, including his groundbreaking collaboration with Stanley Kubrick on the film "2001," has received all of science fiction’s highest awards, and whose visionary contribution to science has earned him the nickname, "Godfather of the Communication Satellite." Read more at The British Interplanetary Society... |
 |
 |
 |
|
||
 |
|
 |
|
||
|
|
| DBED's Cybersecurity Blog |
| Corridor Inc.’s Strategic Partners |
| CENTER MARYLAND |
| PRESSBOX |
| GREATER BALTIMORE COMMITTEE |
